about
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...
Read More
6.15
-0.19
(-3.00%)
1.1M
XNAS Volume
XNAS 18 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Graphite Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..